Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 74459.53 308.49 (0.42%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
1	Zydus Lifesciences Ltd.	Q V PT	1,24,089 Mid Cap	1,244 (4.89%)	27.5	4.6	13.52	14.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Yatharth Hospital & Trauma Care Services Ltd.	Q V PT	8,942 Small Cap	928.05 (0.62%)	49.36	4.9	39.48	45.83	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Wockhardt Ltd.	Q V+ PT	30,814 Small Cap	1,896.10 (-1.32%)	75.34	6.12	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Windlas Biotech Ltd.	Q V PT	1,810 Small Cap	877.25 (-5.00%)	27.24	3.52	16.15	12.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Wanbury Ltd.	Q V+ PT	664 Small Cap	189.75 (5.10%)	15.44	9.89	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Viyash Scientific Ltd.	Q V PT	9,653 Small Cap	218.50 (-2.82%)	56.39	3.43	20.23	2.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Vimta Labs Ltd.	Q V+ PT	2,167 Small Cap	484.85 (-6.88%)	26.97	4.41	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Vijaya Diagnostic Centre Ltd.	Q V+ PT	14,906 Small Cap	1,447.25 (-1.19%)	79.51	14.8	16.66	14.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Venus Remedies Ltd.	Q V+ PT	1,646 Small Cap	1,231.75 (-3.71%)	13.53	2.34	7.02	18.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Unichem Laboratories Ltd.	Q V PT	3,404 Small Cap	483.45 (-4.12%)	11.17	1.24	12.26	24.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,76,306 Large Cap	4,635.15 (1.56%)	83.01	9.6	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Thyrocare Technologies Ltd.	Q V PT	7,274 Small Cap	457 (-11.30%)	50.44	13.14	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Themis Medicare Ltd.	Q V PT	875 Small Cap	95 (-2.56%)	21.89	2.08	8.21	-69.58	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Tarsons Products Ltd.	Q V+ PT	1,552 Small Cap	291.75 (-3.98%)	139.91	2.45	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Take Ltd.	Q V PT	159 Small Cap	10.75 (-3.41%)	12.4	4.96	-41.25	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Syngene International Ltd.	Q V+ PT	16,252 Small Cap	402.60 (1.08%)	76.91	3.44	9.45	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Syncom Formulations (India) Ltd.	Q V+ PT	1,810 Small Cap	19.25 (-5.54%)	21.16	4.11	21.49	39.14	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Suven Life Sciences Ltd.	Q V+ PT	7,293 Small Cap	258.10 (-2.53%)	N/A	13.1	-12.01	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Suraksha Diagnostic Ltd.	Q V PT	1,653 Small Cap	317.40 (-0.69%)	46.18	6.44	17.26	-44.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Supriya Lifescience Ltd.	Q V+ PT	6,810 Small Cap	846.20 (-2.56%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Sun Pharmaceutical Industries Ltd.	Q V+ PT	4,26,662 Large Cap	1,778.25 (0.87%)	38.91	4.78	11.78	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	5,741 Small Cap	176.90 (-3.47%)	3.62	4.36	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Strides Pharma Science Ltd.	Q V+ PT	9,855 Small Cap	1,069.15 (-2.57%)	15.98	2.88	7.94	21.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Solara Active Pharma Sciences Ltd.	Q V PT	3,055 Small Cap	633.05 (-3.34%)	82.7	2.13	-3.27	-145.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	SMS Pharmaceuticals Ltd.	Q V+ PT	4,793 Small Cap	511.75 (5.33%)	46.8	5.95	9.51	7.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Sigachi Industries Ltd.	Q V+ PT	1,009 Small Cap	26.40 (-0.83%)	40.6	1.87	19.91	-146.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Shukra Medtech Ltd.	Q V+ PT	3,317 Small Cap	74.95 (-0.05%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Shilpa Medicare Ltd.	Q V+ PT	18,671 Small Cap	954.65 (2.09%)	62.8	6.95	11.30	12.66	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Shalby Ltd.	Q V+ PT	1,306 Small Cap	120.90 (-1.43%)	33.22	1.29	21.51	-5.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Senores Pharmaceuticals Ltd.	Q V PT	5,221 Small Cap	1,133.60 (-6.97%)	39.11	5.21	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anuh Pharma	87.09	8.86%
Laurus Labs	2,392	6.55%
SMS Pharmaceuticals	511.75	5.33%
Wanbury	189.75	5.10%
Zydus Lifesciences	1,244	4.89%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
RPG Life Sciences	2,572.40	-14.13%
Thyrocare Tech.	457	-11.30%
Gennex Laboratories	8.02	-10.49%
Ind-Swift Labs.	367.40	-10.14%
Cohance Lifesciences	444.45	-7.67%

News about Top Pharma Companies in India

Nov, 2026

Sigachi Industries - Quaterly Results

The sales figure stood at Rs. 1134.85 millions for the September 2026 quarter. The mentioned figure indicates a growth of about 35.19% as compared to Rs. 839.43 millions during the year-ago period.A slender decline of -23.68% was recorded to Rs. 89.77 millions from Rs. 117.62 millions in the corresponding previous quarter.Operating profit surged to 172.97 millions from the corresponding previous quarter of 91.58 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	1134.85	839.43	35.19	2117.61	1949.20	8.64	3790.42	4078.33	-7.06
Other Income	2.19	24.92	-91.21	6.62	64.33	-89.71	82.28	200.77	-59.02
PBIDT	172.97	91.58	88.87	308.98	370.60	-16.63	582.27	943.38	-38.28
Interest	31.63	25.27	25.17	53.49	46.74	14.44	101.34	106.57	-4.91
PBDT	141.34	112.87	25.22	255.49	-839.64	-130.43	-701.20	836.81	-183.79
Depreciation	36.21	33.13	9.30	72.42	72.63	-0.29	144.31	129.22	11.68
PBT	105.13	79.74	31.84	183.07	-912.27	-120.07	-845.51	707.59	-219.49
TAX	15.36	-37.88	-140.55	28.22	-38.45	-173.39	-50.05	230.92	-121.67
Deferred Tax	-8.40	-37.88	-77.82	-16.80	-38.45	-56.31	-54.30	105.18	-151.63
PAT	89.77	117.62	-23.68	154.85	-873.82	-117.72	-795.46	476.67	-266.88
Equity	382.12	382.12	0.00	382.12	382.12	0.00	382.12	382.12	0.00
PBIDTM(%)	15.24	10.91	39.71	14.59	19.01	-23.26	15.36	23.13	-33.59

Oct, 2026

Vimta Labs - Quaterly Results

A fair growth of 9.95% in the revenue at Rs. 1119.83 millions was reported in the September 2026 quarter as compared to Rs. 1018.48 millions during year-ago period.A meek growth of 3.48% was reported for the quarter ended September 2026 to Rs. 206.14 millions from Rs. 199.20 millions.Operating profit surged to 407.78 millions from the corresponding previous quarter of 368.88 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	1119.83	1018.48	9.95	2210.57	1994.12	10.85	4072.90	3439.82	18.40
Other Income	29.04	26.58	9.26	67.16	44.07	52.39	89.89	42.40	112.00
PBIDT	407.78	368.88	10.55	819.01	723.27	13.24	1505.08	1261.89	19.27
Interest	3.85	3.74	2.94	6.22	6.89	-9.72	11.67	19.00	-38.58
PBDT	403.93	365.14	10.62	812.79	716.38	13.46	1477.25	1242.89	18.86
Depreciation	128.68	102.40	25.66	254.16	201.02	26.44	437.72	352.89	24.04
PBT	275.25	262.74	4.76	558.63	515.36	8.40	1039.53	890.00	16.80
TAX	69.11	63.54	8.77	142.07	127.22	11.67	264.41	222.45	18.86
Deferred Tax	1.58	-3.17	-149.84	16.02	-7.23	-321.58	-1.07	12.66	-108.45
PAT	206.14	199.20	3.48	416.56	388.14	7.32	775.12	667.55	16.11
Equity	89.40	89.08	0.36	89.40	89.08	0.36	89.34	44.47	100.90
PBIDTM(%)	36.41	36.22	0.54	37.05	36.27	2.15	36.95	36.68	0.73

Oct, 2026

Sun Pharma. Inds. - Quaterly Results

The sales surged to Rs. 61419.20 millions, up 35.04% for the September 2026 quarter as against Rs. 45481.10 millions during the corresponding quarter previous year.Profit after tax for the quarter ended September 2026 reported a huge growth of 54.42% to Rs. 8712.90 millions from Rs. 5642.20 millions.Operating Profit saw a handsome growth to 17957.40 millions from 12563.80 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	61419.20	45481.10	35.04	118830.50	101429.90	17.16	207546.40	229774.00	-9.67
Other Income	810.10	727.90	11.29	2211.80	1765.00	25.31	4193.30	3791.40	10.60
PBIDT	17957.40	12563.80	42.93	39001.20	32696.20	19.28	66000.20	72168.40	-8.55
Interest	2769.60	2483.30	11.53	5554.40	4867.50	14.11	9478.40	9538.90	-0.63
PBDT	15187.80	10080.50	50.67	33131.50	24952.30	32.78	51058.40	62629.50	-18.48
Depreciation	3157.90	3363.00	-6.10	6237.10	6472.20	-3.63	13117.20	12867.40	1.94
PBT	12029.90	6717.50	79.08	26894.40	18480.10	45.53	37941.20	49762.10	-23.75
TAX	3317.00	1075.30	208.47	7030.10	5387.30	30.49	11707.00	7481.30	56.48
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	8712.90	5642.20	54.42	19864.30	13092.80	51.72	26234.20	42280.80	-37.95
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	29.24	27.62	5.84	32.82	32.24	1.82	31.80	31.41	1.25

Oct, 2026

Sun Pharma’s consolidated net profit falls 36% in Q2

The total consolidated income of the company has increased by 11.83% at Rs 16,716.03 crore for Q2FY27

Oct, 2026

Strides Pharma Science informs about analyst meet outcome

Pursuant to Regulations 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Strides Pharma Science has informed that the audio recording of the Earnings Call held for investors and analysts today, Friday, October 30, 2026, at 10:00 hrs IST, to discuss Company’s unaudited financial results for the quarter and half year ended September 30, 2026, has been made available on the Company’s website at: https://www.strides.com/investors/financial-performance/quarterly-results

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Vimta Labs informs about unaudited financial results

Vimta Labs has enclosed unaudited Financial Results as per Regulation 33 of the SEBI (LODR) Regulations, 2015 for the 02nd Quarter and Half Year ended 30th September 2026 along with Limited Review Report. The said Financial Results were duly reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company, at their respective meetings held today. Further to earlier intimation dated 6th May 2026 regarding the proposed incorporation of a wholly owned subsidiary in the USA, the Board of Directors of the Company, at its meeting held today, took note of the incorporation of Vimta Labs LLC as a wholly owned subsidiary of the Company. The meeting of the Board of Directors of the Company commenced at 10:30 AM and concluded at 01:00 PM.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Zydus Lifesciences Ltd.	1,24,089 Crore
2	Yatharth Hospital & Trauma Care Services Ltd.	8,942 Crore
3	Wockhardt Ltd.	30,814 Crore
4	Windlas Biotech Ltd.	1,810 Crore
5	Wanbury Ltd.	664 Crore
6	Viyash Scientific Ltd.	9,653 Crore
7	Vimta Labs Ltd.	2,167 Crore
8	Vijaya Diagnostic Centre Ltd.	14,906 Crore
9	Venus Remedies Ltd.	1,646 Crore
10	Unichem Laboratories Ltd.	3,404 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,635	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,392	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,678	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,928	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,489	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,244	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,350	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Sigachi Industries - Quaterly Results

Vimta Labs - Quaterly Results

Sun Pharma. Inds. - Quaterly Results

Sun Pharma’s consolidated net profit falls 36% in Q2

Strides Pharma Science informs about analyst meet outcome

Vimta Labs informs about unaudited financial results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?